BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection

Affiliations

• ¹ GRAIL LLC, Menlo Park, California, USA.
• ² Guardant Health, Redwood City, California, USA.
• ³ Freenome, South San Francisco, California, USA.
• ⁴ Novartis, Cambridge, Massachusetts, USA.
• ⁵ Illumina, San Diego, California, USA.
• ⁶ Lungevity Foundation, Bethesda, Maryland, USA.
• ⁷ Quest Diagnostics, Irvine, California, USA.
• ⁸ Open Commons Consortium, Chicago, Illinois, USA.
• ⁹ Prevent Cancer Foundation, Alexandria, Virginia, USA.
• ¹⁰ University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
• ¹¹ University of Southern California, Los Angeles, California, USA.
• ¹² Delfi Diagnostics, Palo Alto, California, USA.
• ¹³ Pfizer, San Diego, California, USA.
• ¹⁴ Bio-Rad Laboratories Inc, Digital Biology Group, Pleasanton, California, USA.
• ¹⁵ AstraZeneca, Gaithersburg, Maryland, USA.
• ¹⁶ Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ¹⁷ Friends of Cancer Research, Washington, DC, USA.
• ¹⁸ EXACT Sciences, Madison, Wisconsin, USA.
• ¹⁹ GlaxoSmithKline, Collegeville, Pennsylvania, USA.
• ²⁰ BLOODPAC, Chicago, Illinois, USA.